[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global H3N2 Infection Treatment Market Survey and Trend Research 2018

June 2018 | 93 pages | ID: G7F22BA933BEN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (AIMM Therapeutics B.V., Aphios Corporation, Crucell N.V., CSL Limited, ILiAD Biotechnologies, LLC, ILiAD Biotechnologies, LLC, Inovio Pharmaceuticals, Inc., Johnson & Johnson, Medicago Inc., MedImmune, LLC, Mucosis B.V., NanoViricides, Inc., Novavax, Inc., OPKO Health, Inc., Sarepta Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Visterra, Inc., Zydus Cadila Healthcare Limited etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 H3N2 Infection Treatment Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 H3N2 INFECTION TREATMENT MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 AIMM Therapeutics B.V. (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Aphios Corporation (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Crucell N.V. (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 CSL Limited (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 ILiAD Biotechnologies, LLC (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 ILiAD Biotechnologies, LLC (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Inovio Pharmaceuticals, Inc. (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Medicago Inc. (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 MedImmune, LLC (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Mucosis B.V. (Company Overview, Sales Data etc.)
4.12 NanoViricides, Inc. (Company Overview, Sales Data etc.)
4.13 Novavax, Inc. (Company Overview, Sales Data etc.)
4.14 OPKO Health, Inc. (Company Overview, Sales Data etc.)
4.15 Sarepta Therapeutics, Inc. (Company Overview, Sales Data etc.)
4.16 Takeda Pharmaceutical Company Limited (Company Overview, Sales Data etc.)
4.17 Visterra, Inc. (Company Overview, Sales Data etc.)
4.18 Zydus Cadila Healthcare Limited (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

TABLE GLOBAL H3N2 INFECTION TREATMENT MARKET 2012-2017, BY TYPE, IN USD MILLION

Table Global H3N2 Infection Treatment Market 2012-2017, by Type, in Volume
Table Global H3N2 Infection Treatment Market Forecast 2018-2023, by Type, in USD Million
Table Global H3N2 Infection Treatment Market Forecast 2018-2023, by Type, in Volume
Table AIMM Therapeutics B.V. Overview List
Table H3N2 Infection Treatment Business Operation of AIMM Therapeutics B.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aphios Corporation Overview List
Table H3N2 Infection Treatment Business Operation of Aphios Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Crucell N.V. Overview List
Table H3N2 Infection Treatment Business Operation of Crucell N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited Overview List
Table H3N2 Infection Treatment Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ILiAD Biotechnologies, LLC Overview List
Table H3N2 Infection Treatment Business Operation of ILiAD Biotechnologies, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ILiAD Biotechnologies, LLC Overview List
Table H3N2 Infection Treatment Business Operation of ILiAD Biotechnologies, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Inovio Pharmaceuticals, Inc. Overview List
Table H3N2 Infection Treatment Business Operation of Inovio Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table H3N2 Infection Treatment Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Medicago Inc. Overview List
Table H3N2 Infection Treatment Business Operation of Medicago Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune, LLC Overview List
Table H3N2 Infection Treatment Business Operation of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mucosis B.V. Overview List
Table H3N2 Infection Treatment Business Operation of Mucosis B.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NanoViricides, Inc. Overview List
Table H3N2 Infection Treatment Business Operation of NanoViricides, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novavax, Inc. Overview List
Table H3N2 Infection Treatment Business Operation of Novavax, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OPKO Health, Inc. Overview List
Table H3N2 Infection Treatment Business Operation of OPKO Health, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics, Inc. Overview List
Table H3N2 Infection Treatment Business Operation of Sarepta Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Overview List
Table H3N2 Infection Treatment Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Visterra, Inc. Overview List
Table H3N2 Infection Treatment Business Operation of Visterra, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zydus Cadila Healthcare Limited Overview List
Table H3N2 Infection Treatment Business Operation of Zydus Cadila Healthcare Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global H3N2 Infection Treatment Sales Revenue 2012-2017, by Companies, in USD Million
Table Global H3N2 Infection Treatment Sales Revenue Share, by Companies, in USD Million
Table Global H3N2 Infection Treatment Sales Volume 2012-2017, by Companies, in Volume
Table Global H3N2 Infection Treatment Sales Revenue Share, by Companies in 2017, in Volume
Table H3N2 Infection Treatment Demand 2012-2017, by Application, in USD Million
Table H3N2 Infection Treatment Demand 2012-2017, by Application, in Volume
Table H3N2 Infection Treatment Demand Forecast 2018-2023, by Application, in USD Million
Table H3N2 Infection Treatment Demand Forecast 2018-2023, by Application, in Volume
Table Global H3N2 Infection Treatment Market 2012-2017, by Region, in USD Million
Table Global H3N2 Infection Treatment Market 2012-2017, by Region, in Volume
Table H3N2 Infection Treatment Market Forecast 2018-2023, by Region, in USD Million
Table H3N2 Infection Treatment Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure H3N2 Infection Treatment Industry Chain Structure
Figure Global H3N2 Infection Treatment Market Growth 2012-2017, by Type, in USD Million
Figure Global H3N2 Infection Treatment Market Growth 2012-2017, by Type, in Volume
Figure Global H3N2 Infection Treatment Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global H3N2 Infection Treatment Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications